Clinical trials
Completed Borderline Personality Disorder trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 6 |
| 2005 | 3 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Minnesota | 4 |
| Mclean Hospital | 3 |
| New York State Psychiatric Institute | 3 |
| University of Chicago | 3 |
| University of Washington | 3 |
| Boehringer Ingelheim | 2 |
| Eli Lilly and Company | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| Ohio State University | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Borderline Personality Disorder | 51 |
| Anxiety Disorders | 2 |
| Disruptive, Impulse Control, and Conduct Disorders | 2 |
| Major Depressive Disorder | 2 |
| Personality Disorders | 2 |
| Alcoholism | 1 |
| Bipolar Disorder | 1 |
| Dysthymic Disorder | 1 |
| Fibromyalgia | 1 |
| Headache | 1 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.